BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 18355196)

  • 1. Safety of etanercept therapy in a patient with psoriasis, Down's syndrome and concomitant hepatitis C virus infection.
    Alcaide AJ; Barrera MV; Habicheyn S; López N; Mendiola MV; Herrera E
    J Eur Acad Dermatol Venereol; 2008 Dec; 22(12):1514-6. PubMed ID: 18355196
    [No Abstract]   [Full Text] [Related]  

  • 2. Etanercept therapy for psoriasis in a patient with concomitant hepatitis C and liver transplant.
    Collazo MH; González JR; Torres EA
    P R Health Sci J; 2008 Dec; 27(4):346-7. PubMed ID: 19069362
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Etanercept therapy in two patients with psoriasis and concomitant hepatitis C.
    De Simone C; Paradisi A; Capizzi R; Carbone A; Siciliano M; Amerio PL
    J Am Acad Dermatol; 2006 Jun; 54(6):1102-4. PubMed ID: 16713482
    [No Abstract]   [Full Text] [Related]  

  • 4. Efficacy and safety of etanercept in patients with psoriasis and hepatitis C.
    Ventura F; Gomes J; Duarte Mda L; Fernandes JC; Brito C
    Eur J Dermatol; 2010; 20(6):808-9. PubMed ID: 20923749
    [No Abstract]   [Full Text] [Related]  

  • 5. Etanercept monotherapy for a patient with psoriasis, psoriatic arthritis, and concomitant hepatitis C infection.
    Rokhsar C; Rabhan N; Cohen SR
    J Am Acad Dermatol; 2006 Feb; 54(2):361-2. PubMed ID: 16443079
    [No Abstract]   [Full Text] [Related]  

  • 6. Safety of etanercept in patients with psoriasis and hepatitis C virus assessed by liver histopathology: preliminary data.
    Paradisi A; Caldarola G; Capizzi R; Siciliano M; Annichiarico E; Vecchio FM; Amerio PL; De Simone C
    J Am Acad Dermatol; 2010 Jun; 62(6):1067-9. PubMed ID: 20466184
    [No Abstract]   [Full Text] [Related]  

  • 7. Effective control of psoriasis by etanercept in a patient with HCV-related diseases.
    Piccolo D; Di Cesare A; Fargnoli MC; Paoloni M; Vecchiotti S; Peris K
    Eur J Dermatol; 2008; 18(4):459-60. PubMed ID: 18573723
    [No Abstract]   [Full Text] [Related]  

  • 8. Long-term management of HIV/hepatitis C virus associated psoriasis with etanercept.
    Di Lernia V; Zoboli G; Ficarelli E
    Indian J Dermatol Venereol Leprol; 2013; 79(3):444. PubMed ID: 23619459
    [No Abstract]   [Full Text] [Related]  

  • 9. Psoriasis and hepatitis C treated with anti-TNF alpha therapy (etanercept).
    Cecchi R; Bartoli L
    Dermatol Online J; 2006 Dec; 12(7):4. PubMed ID: 17459290
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Etanercept in the treatment of psoriasis and psoriatic arthritis with concomitant hepatitis C virus infection: clinical and virological study in three patients.
    Zanni M; Missale G; Santilli D; Di Nuzzo S
    Eur J Dermatol; 2011; 21(4):564-7. PubMed ID: 21543290
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Etanercept for the treatment of psoriasis.
    Bissonnette R
    Skin Therapy Lett; 2006 Feb; 11(1):1-4. PubMed ID: 16485060
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Etanercept therapy in a hepatitis B virus (HBV)-positive psoriatic patient developing a monoclonal gammopathy of undetermined significance.
    Prignano F; Ricceri F; Pescitelli L; Bonciani D; Lotti T
    Int J Dermatol; 2011 Aug; 50(8):999-1001. PubMed ID: 21781077
    [No Abstract]   [Full Text] [Related]  

  • 13. Palmoplantar pustulosis with arthro-osteitis: successful treatment with etanercept and acitretin.
    Antoniou C; Nicolaidou E; Moustou AE; Stratigos A; Katsambas A
    J Eur Acad Dermatol Venereol; 2009 Jul; 23(7):854-5. PubMed ID: 19646137
    [No Abstract]   [Full Text] [Related]  

  • 14. Adolescent plaque psoriasis: our experience using etanercept.
    Ruiz-Villaverde R; Sánchez-Cano D; Abalos-Medina G
    J Eur Acad Dermatol Venereol; 2009 Aug; 23(8):976-7. PubMed ID: 19207668
    [No Abstract]   [Full Text] [Related]  

  • 15. Three-year registry data on biological treatment for psoriasis: the influence of patient characteristics on treatment outcome.
    Driessen RJ; Boezeman JB; van de Kerkhof PC; de Jong EM
    Br J Dermatol; 2009 Mar; 160(3):670-5. PubMed ID: 19210502
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Safety of antitumour necrosis factor-α therapy in psoriatic patients with hepatitis B virus infection.
    Nosotti L; Francesconi F; Izzi S; Berardesca E; Morrone A; Bonifati C
    Br J Dermatol; 2010 Jun; 162(6):1408-10. PubMed ID: 20184582
    [No Abstract]   [Full Text] [Related]  

  • 17. Etanercept in psoriasis treatment.
    Pietrzak A; Chodorowska G; Urban J; Roliński J; Pietrzak B
    Ann Univ Mariae Curie Sklodowska Med; 2003; 58(1):222-6. PubMed ID: 15314989
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Etanercept for the treatment of severe childhood psoriasis.
    Papoutsaki M; Costanzo A; Mazzotta A; Gramiccia T; Soda R; Chimenti S
    Br J Dermatol; 2006 Jan; 154(1):181-3. PubMed ID: 16403117
    [No Abstract]   [Full Text] [Related]  

  • 19. Cessation of cyclosporine therapy by treatment with etanercept in patients with severe psoriasis.
    Yamauchi PS; Lowe NJ
    J Am Acad Dermatol; 2006 Mar; 54(3 Suppl 2):S135-8. PubMed ID: 16488328
    [No Abstract]   [Full Text] [Related]  

  • 20. Is etanercept safe for treating plaque psoriasis in a patient with chronic hepatitis C virus infection?
    Gandhi RK; Pickup T; Sheth PB
    Arch Dermatol; 2010 Oct; 146(10):1151-2. PubMed ID: 20956650
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.